Mitochondrial dysfunction on TikTok: separating symptom claims from peptide research

A recent TikTok from Dr. Jaban Moore walks viewers through a familiar set of complaints—fatigue, weakness, cognitive impairment—and labels them as possible signs of mitochondrial dysfunction. The video’s caption asks viewers to “discover the signs and symptoms of this hidden condition” and hints at ways to “navigate its challenges.” It’s the kind of short, symptom-forward content that performs well on social platforms, but it also compresses a complex cellular biology topic into a 15-second narrative. This article reviews what the clip claims, what the research neighborhood actually covers, and where the evidence stands—especially in relation to research peptides sold for laboratory use only.

What the clip is claiming

The core claim is that common, non-specific symptoms—fatigue, weakness, and cognitive impairment—can be traced to mitochondrial dysfunction. The clip implies that this “hidden condition” is underrecognized and that recognizing it is a key step toward addressing it. It does not specify a diagnostic test, a treatment protocol, or a particular supplement. Instead, it positions mitochondrial dysfunction as a unifying explanation for a set of symptoms that are also seen in many other conditions, including sleep deprivation, thyroid disorders, depression, and chronic infection.

What the research neighborhood actually covers

Mitochondrial dysfunction is a well-studied phenomenon in basic science and clinical research. It refers to impaired oxidative phosphorylation, reduced ATP production, increased reactive oxygen species, and altered mitochondrial dynamics. These changes have been observed in a wide range of conditions—from inherited mitochondrial diseases to age-related disorders, neurodegenerative diseases, metabolic syndrome, and even chronic fatigue syndrome. However, the research does not support the idea that fatigue or brain fog in a generally healthy person is a reliable indicator of mitochondrial failure. In most cases, these symptoms are multifactorial, and mitochondrial dysfunction is one of many possible contributing factors, not a standalone diagnosis.

Limits, missing context, and what a 15-second clip cannot show

A short video cannot convey the nuance of mitochondrial biology. It cannot explain that mitochondrial dysfunction is not a single disease but a spectrum of biochemical changes that vary by tissue and trigger. It also cannot show that symptoms like fatigue and cognitive impairment are notoriously non-specific—they appear in dozens of conditions, and even in healthy individuals after a poor night’s sleep. The clip also omits the fact that diagnosing true mitochondrial dysfunction requires specialized testing (e.g., muscle biopsy, genetic panels, or advanced imaging) and is typically reserved for cases where a mitochondrial disorder is strongly suspected. For the general public, the video’s framing may lead to self-diagnosis and unnecessary worry, or to seeking unproven supplements that claim to “boost mitochondria.”

How this maps to catalog research compounds

While the clip does not mention any specific peptide, the broader online conversation around mitochondrial health often intersects with research peptides. In the catalog, several compounds are studied for their potential effects on cellular energy and mitochondrial function, though none are approved for human use. For example, SS-31 (Elamipretide) is a peptide that has been investigated in preclinical models for its ability to stabilize cardiolipin in the inner mitochondrial membrane, thereby improving ATP production and reducing oxidative stress. MOTS-c is another peptide that has been studied for its role in regulating metabolic pathways and mitochondrial function, particularly in response to exercise. NAD+ is a coenzyme that is central to cellular respiration and has been a focus of research on aging and mitochondrial health. Additionally, 5-Amino-1MQ has been explored in animal studies for its potential to increase NAD+ levels and enhance energy expenditure. These compounds are sold for research purposes only—they are not dietary supplements or medications. The clip’s vague reference to “navigating challenges” does not align with any specific peptide, and any attempt to connect these symptoms to a particular product would be speculative.

Research-use caveat

All peptides mentioned here are intended for laboratory research and in vitro or animal studies only. They are not approved for human consumption, diagnosis, or treatment. The symptoms described in the TikTok clip—fatigue, weakness, cognitive impairment—should be evaluated by a qualified healthcare professional. Self-experimentation with research chemicals is unsafe and unethical. Researchers must follow institutional guidelines and ensure proper handling and disposal.